Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.47896970 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.47896970 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08723112 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.08723112 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.26530041 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07799776 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99659075 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.76907004 |
9 | negative regulation of cell killing (GO:0031342) | 4.76907004 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.71494717 |
11 | bile acid biosynthetic process (GO:0006699) | 4.70096761 |
12 | glyoxylate metabolic process (GO:0046487) | 4.62898524 |
13 | cysteine metabolic process (GO:0006534) | 4.60123847 |
14 | sulfur amino acid catabolic process (GO:0000098) | 4.55262245 |
15 | complement activation, alternative pathway (GO:0006957) | 4.44635492 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.43317645 |
17 | kynurenine metabolic process (GO:0070189) | 4.37192941 |
18 | tryptophan catabolic process (GO:0006569) | 4.27092526 |
19 | indole-containing compound catabolic process (GO:0042436) | 4.27092526 |
20 | indolalkylamine catabolic process (GO:0046218) | 4.27092526 |
21 | protein carboxylation (GO:0018214) | 4.23901421 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.23901421 |
23 | lysine metabolic process (GO:0006553) | 4.23399806 |
24 | lysine catabolic process (GO:0006554) | 4.23399806 |
25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23267984 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18761281 |
27 | regulation of triglyceride catabolic process (GO:0010896) | 4.14535174 |
28 | bile acid metabolic process (GO:0008206) | 4.07926984 |
29 | regulation of protein activation cascade (GO:2000257) | 4.07080732 |
30 | homocysteine metabolic process (GO:0050667) | 4.07076768 |
31 | tryptophan metabolic process (GO:0006568) | 4.06278902 |
32 | short-chain fatty acid metabolic process (GO:0046459) | 4.05554919 |
33 | urea cycle (GO:0000050) | 4.03008969 |
34 | urea metabolic process (GO:0019627) | 4.03008969 |
35 | fatty acid beta-oxidation (GO:0006635) | 3.96583427 |
36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95403285 |
37 | ethanol oxidation (GO:0006069) | 3.95150648 |
38 | negative regulation of fibrinolysis (GO:0051918) | 3.93697842 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92313133 |
40 | coenzyme catabolic process (GO:0009109) | 3.90898132 |
41 | acetyl-CoA metabolic process (GO:0006084) | 3.88245030 |
42 | plasma lipoprotein particle clearance (GO:0034381) | 3.87818091 |
43 | tyrosine metabolic process (GO:0006570) | 3.86339877 |
44 | regulation of complement activation (GO:0030449) | 3.86338679 |
45 | fatty acid oxidation (GO:0019395) | 3.82143913 |
46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80530584 |
47 | amino-acid betaine metabolic process (GO:0006577) | 3.79795372 |
48 | serine family amino acid catabolic process (GO:0009071) | 3.79445513 |
49 | valine metabolic process (GO:0006573) | 3.79355160 |
50 | regulation of fibrinolysis (GO:0051917) | 3.76994255 |
51 | alpha-amino acid catabolic process (GO:1901606) | 3.76194181 |
52 | phospholipid homeostasis (GO:0055091) | 3.75176441 |
53 | lipid oxidation (GO:0034440) | 3.75086381 |
54 | aromatic amino acid family metabolic process (GO:0009072) | 3.73593095 |
55 | aspartate family amino acid catabolic process (GO:0009068) | 3.71168292 |
56 | fatty acid catabolic process (GO:0009062) | 3.70547491 |
57 | triglyceride homeostasis (GO:0070328) | 3.70335335 |
58 | acylglycerol homeostasis (GO:0055090) | 3.70335335 |
59 | nitrogen cycle metabolic process (GO:0071941) | 3.69501066 |
60 | regulation of cholesterol metabolic process (GO:0090181) | 3.64656505 |
61 | microglial cell activation (GO:0001774) | 3.64239610 |
62 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62196577 |
63 | cellular amino acid catabolic process (GO:0009063) | 3.61090994 |
64 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.58391683 |
65 | reverse cholesterol transport (GO:0043691) | 3.55528724 |
66 | cellular ketone body metabolic process (GO:0046950) | 3.54946792 |
67 | glutamate metabolic process (GO:0006536) | 3.52413922 |
68 | monocarboxylic acid catabolic process (GO:0072329) | 3.49409417 |
69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48927261 |
70 | detection of other organism (GO:0098543) | 3.47566898 |
71 | cellular modified amino acid catabolic process (GO:0042219) | 3.46774847 |
72 | fatty acid transmembrane transport (GO:1902001) | 3.46263682 |
73 | protein-lipid complex remodeling (GO:0034368) | 3.43585248 |
74 | macromolecular complex remodeling (GO:0034367) | 3.43585248 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43585248 |
76 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.42737961 |
77 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.40949099 |
78 | very long-chain fatty acid metabolic process (GO:0000038) | 3.39996236 |
79 | cholesterol efflux (GO:0033344) | 3.39566048 |
80 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38359851 |
81 | modulation by symbiont of host defense response (GO:0052031) | 3.38359851 |
82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38359851 |
83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38359851 |
84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38359851 |
85 | modulation by symbiont of host immune response (GO:0052553) | 3.38359851 |
86 | branched-chain amino acid catabolic process (GO:0009083) | 3.38021146 |
87 | heme transport (GO:0015886) | 3.36649170 |
88 | organic acid catabolic process (GO:0016054) | 3.36166510 |
89 | carboxylic acid catabolic process (GO:0046395) | 3.36166510 |
90 | cellular response to epinephrine stimulus (GO:0071872) | 3.35199214 |
91 | detection of molecule of bacterial origin (GO:0032490) | 3.34645693 |
92 | phospholipid efflux (GO:0033700) | 3.33516556 |
93 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33489198 |
94 | acyl-CoA biosynthetic process (GO:0071616) | 3.32942900 |
95 | thioester biosynthetic process (GO:0035384) | 3.32942900 |
96 | cholesterol homeostasis (GO:0042632) | 3.32692071 |
97 | regulation of cholesterol homeostasis (GO:2000188) | 3.31843406 |
98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.31622361 |
99 | regulation of cholesterol esterification (GO:0010872) | 3.31121748 |
100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30757794 |
101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29907150 |
102 | sterol homeostasis (GO:0055092) | 3.28657742 |
103 | bile acid and bile salt transport (GO:0015721) | 3.28136072 |
104 | cellular glucuronidation (GO:0052695) | 3.28126984 |
105 | branched-chain amino acid metabolic process (GO:0009081) | 3.28090820 |
106 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.27573871 |
107 | cofactor catabolic process (GO:0051187) | 3.27257620 |
108 | positive regulation of lipid catabolic process (GO:0050996) | 3.26871708 |
109 | activated T cell proliferation (GO:0050798) | 3.26636184 |
110 | negative T cell selection (GO:0043383) | 3.24014979 |
111 | macrophage activation involved in immune response (GO:0002281) | 3.22683684 |
112 | positive thymic T cell selection (GO:0045059) | 3.22539374 |
113 | regulation of sequestering of triglyceride (GO:0010889) | 3.22492909 |
114 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22077334 |
115 | positive T cell selection (GO:0043368) | 3.21929429 |
116 | negative regulation of cholesterol transport (GO:0032375) | 3.20656531 |
117 | negative regulation of sterol transport (GO:0032372) | 3.20656531 |
118 | detection of bacterium (GO:0016045) | 3.20634205 |
119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19438004 |
120 | drug transmembrane transport (GO:0006855) | 3.19359454 |
121 | negative thymic T cell selection (GO:0045060) | 3.18592238 |
122 | creatine metabolic process (GO:0006600) | 3.17629350 |
123 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.15975832 |
124 | ketone body metabolic process (GO:1902224) | 3.15260421 |
125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15234198 |
126 | response to interleukin-15 (GO:0070672) | 3.14653912 |
127 | serine family amino acid metabolic process (GO:0009069) | 3.14509562 |
128 | biotin metabolic process (GO:0006768) | 3.14072583 |
129 | fatty acid elongation (GO:0030497) | 3.11836820 |
130 | negative regulation of lipase activity (GO:0060192) | 3.09275580 |
131 | detection of external biotic stimulus (GO:0098581) | 3.09107048 |
132 | ethanol metabolic process (GO:0006067) | 3.08942404 |
133 | carnitine shuttle (GO:0006853) | 3.08506734 |
134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08371408 |
135 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08371408 |
136 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02762200 |
137 | neutrophil activation involved in immune response (GO:0002283) | 3.02679041 |
138 | B cell receptor signaling pathway (GO:0050853) | 2.97956138 |
139 | cellular extravasation (GO:0045123) | 2.96443933 |
140 | response to epinephrine (GO:0071871) | 2.93035342 |
141 | macrophage activation (GO:0042116) | 2.90092526 |
142 | cellular response to interleukin-15 (GO:0071350) | 2.85403949 |
143 | regulation of platelet aggregation (GO:0090330) | 2.84128635 |
144 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81819986 |
145 | regulation of beta-amyloid formation (GO:1902003) | 2.79012724 |
146 | regulation of relaxation of muscle (GO:1901077) | 2.78247674 |
147 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.76775381 |
148 | T cell selection (GO:0045058) | 2.75582474 |
149 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.74470719 |
150 | gas transport (GO:0015669) | 2.72368226 |
151 | leukocyte aggregation (GO:0070486) | 2.71298397 |
152 | response to methylmercury (GO:0051597) | 2.70624740 |
153 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68016035 |
154 | positive regulation of granulocyte differentiation (GO:0030854) | 2.67116537 |
155 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.65522871 |
156 | oxygen transport (GO:0015671) | 2.64317991 |
157 | detection of biotic stimulus (GO:0009595) | 2.58179206 |
158 | neutrophil activation (GO:0042119) | 2.56078304 |
159 | regulation of necroptotic process (GO:0060544) | 2.56004361 |
160 | thymic T cell selection (GO:0045061) | 2.54358491 |
161 | T cell migration (GO:0072678) | 2.54283450 |
162 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.51953386 |
163 | nerve growth factor signaling pathway (GO:0038180) | 2.45965615 |
164 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.45918625 |
165 | negative regulation of interleukin-12 production (GO:0032695) | 2.45671809 |
166 | skeletal muscle adaptation (GO:0043501) | 2.45611693 |
167 | regulation of Rap GTPase activity (GO:0032317) | 2.43248126 |
168 | macroautophagy (GO:0016236) | 2.42210778 |
169 | hepatocyte apoptotic process (GO:0097284) | 2.40631365 |
170 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40533846 |
171 | response to host immune response (GO:0052572) | 2.40533846 |
172 | myeloid cell development (GO:0061515) | 2.40149648 |
173 | granulocyte activation (GO:0036230) | 2.39514093 |
174 | positive regulation of B cell differentiation (GO:0045579) | 2.38982389 |
175 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.37566859 |
176 | negative regulation of neurotransmitter transport (GO:0051589) | 2.37184815 |
177 | myeloid cell activation involved in immune response (GO:0002275) | 2.36688052 |
178 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36671677 |
179 | hemoglobin metabolic process (GO:0020027) | 2.34598979 |
180 | megakaryocyte development (GO:0035855) | 2.34264070 |
181 | erythrocyte development (GO:0048821) | 2.33137832 |
182 | regulation of cellular amide metabolic process (GO:0034248) | 2.32049608 |
183 | negative regulation of adaptive immune response (GO:0002820) | 2.31985233 |
184 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31959805 |
185 | actin-myosin filament sliding (GO:0033275) | 2.31773041 |
186 | muscle filament sliding (GO:0030049) | 2.31773041 |
187 | response to peptidoglycan (GO:0032494) | 2.31231902 |
188 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.30608766 |
189 | negative regulation of B cell mediated immunity (GO:0002713) | 2.28562837 |
190 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.28562837 |
191 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.27130316 |
192 | cellular response to ethanol (GO:0071361) | 2.26468411 |
193 | response to muramyl dipeptide (GO:0032495) | 2.26362022 |
194 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.25713783 |
195 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.25535332 |
196 | neutrophil mediated immunity (GO:0002446) | 2.25102229 |
197 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.24836386 |
198 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.24053484 |
199 | regulation of B cell differentiation (GO:0045577) | 2.23604575 |
200 | response to host defenses (GO:0052200) | 2.20792694 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.48867018 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20856207 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.42458639 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.31474879 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.80072144 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74057905 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.33206851 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09918839 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.75032595 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.43457911 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18644348 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.80112896 |
13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.73253993 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58382444 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.39224275 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36922357 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31595428 |
18 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27897177 |
19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24177609 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22222486 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15652686 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11978622 |
23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95981005 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92849678 |
25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.92051610 |
26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.80149292 |
27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72442200 |
28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70798035 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68958157 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.67337467 |
31 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64869391 |
32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61985929 |
33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59632894 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59174611 |
35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54246326 |
36 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52779718 |
37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.52705300 |
38 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48248665 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46042781 |
40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42667842 |
41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40836995 |
42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40489646 |
43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35784716 |
44 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.32183654 |
45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32098013 |
46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28066122 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27627682 |
48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27297295 |
49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27266775 |
50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25853192 |
51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25325736 |
52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25325736 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22802295 |
54 | MYB_26560356_Chip-Seq_TH1_Human | 1.22194305 |
55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21314753 |
56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20267195 |
57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20253632 |
58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19702913 |
59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19128272 |
60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18765748 |
61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18722370 |
62 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18097728 |
63 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18097728 |
64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17276971 |
65 | * MAF_26560356_Chip-Seq_TH1_Human | 1.17257215 |
66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17025198 |
67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16339571 |
68 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15965274 |
69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12775589 |
70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12730555 |
71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12295213 |
72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11818203 |
73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11467886 |
74 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.10937779 |
75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10924864 |
76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09091723 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09068658 |
78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08803493 |
79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08795101 |
80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07821796 |
81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07325293 |
82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06388148 |
83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06104762 |
84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06022137 |
85 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.05835770 |
86 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04880897 |
87 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04241140 |
88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04202713 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04087912 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03095053 |
91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02183178 |
92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02166701 |
93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99574906 |
94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98949031 |
95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98731278 |
96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98196810 |
97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96717845 |
98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92160622 |
99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90707354 |
100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90536057 |
101 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89160605 |
102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89083025 |
103 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88314904 |
104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88055416 |
105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88039709 |
106 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87942116 |
107 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87789810 |
108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87203665 |
109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86980733 |
110 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86978747 |
111 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86759702 |
112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86737918 |
113 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85683920 |
114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83884766 |
115 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83728657 |
116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83456381 |
117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82799745 |
118 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.82342758 |
119 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82154727 |
120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81517317 |
121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81178689 |
122 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80863820 |
123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80714673 |
124 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80074301 |
125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78472827 |
126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78365963 |
127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78101478 |
128 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77494787 |
129 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76851543 |
130 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76095456 |
131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76074124 |
132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75232056 |
133 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74977495 |
134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.74600440 |
135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74186269 |
136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74071965 |
137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73589311 |
138 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73395436 |
139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72812223 |
140 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72390824 |
141 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.71602042 |
142 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.71485931 |
143 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71378869 |
144 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70783936 |
145 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.70534264 |
146 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.70219491 |
147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69061167 |
148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.67907256 |
149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67436651 |
150 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67228741 |
151 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.67214173 |
152 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65330022 |
153 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64357842 |
154 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63992567 |
155 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63032949 |
156 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.63006208 |
157 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62756656 |
158 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.61292327 |
159 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.61166177 |
160 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.59939181 |
161 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59843088 |
162 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59094096 |
163 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58116473 |
164 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.57280583 |
165 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56988002 |
166 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56054850 |
167 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54766579 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.49123528 |
2 | MP0005360_urolithiasis | 5.80848044 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.97592045 |
4 | MP0005365_abnormal_bile_salt | 4.93614382 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.09599918 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.99968075 |
7 | MP0003252_abnormal_bile_duct | 3.42730975 |
8 | MP0003303_peritoneal_inflammation | 2.91888167 |
9 | MP0010329_abnormal_lipoprotein_level | 2.88388719 |
10 | MP0003195_calcinosis | 2.85571545 |
11 | MP0005083_abnormal_biliary_tract | 2.77988692 |
12 | MP0009840_abnormal_foam_cell | 2.75795546 |
13 | MP0000569_abnormal_digit_pigmentation | 2.60705397 |
14 | MP0005332_abnormal_amino_acid | 2.43769398 |
15 | MP0001835_abnormal_antigen_presentation | 2.35035498 |
16 | MP0001666_abnormal_nutrient_absorption | 2.29618727 |
17 | MP0008260_abnormal_autophagy | 2.28521040 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.28430113 |
19 | MP0003763_abnormal_thymus_physiology | 2.23363933 |
20 | MP0003436_decreased_susceptibility_to | 2.22590494 |
21 | MP0002118_abnormal_lipid_homeostasis | 2.13301017 |
22 | MP0001800_abnormal_humoral_immune | 2.03433660 |
23 | MP0004130_abnormal_muscle_cell | 1.99277201 |
24 | MP0000609_abnormal_liver_physiology | 1.91988591 |
25 | MP0003183_abnormal_peptide_metabolism | 1.90688065 |
26 | MP0002419_abnormal_innate_immunity | 1.85538372 |
27 | MP0005000_abnormal_immune_tolerance | 1.84698092 |
28 | MP0005464_abnormal_platelet_physiology | 1.84565209 |
29 | MP0005671_abnormal_response_to | 1.84461028 |
30 | MP0000685_abnormal_immune_system | 1.82863195 |
31 | MP0003646_muscle_fatigue | 1.78861163 |
32 | MP0005025_abnormal_response_to | 1.75635151 |
33 | MP0005387_immune_system_phenotype | 1.71291104 |
34 | MP0001790_abnormal_immune_system | 1.71291104 |
35 | MP0003172_abnormal_lysosome_physiology | 1.70397061 |
36 | MP0009785_altered_susceptibility_to | 1.69795333 |
37 | MP0002138_abnormal_hepatobiliary_system | 1.69383374 |
38 | MP0002723_abnormal_immune_serum | 1.65790896 |
39 | MP0002837_dystrophic_cardiac_calcinosis | 1.64721049 |
40 | MP0002420_abnormal_adaptive_immunity | 1.63751738 |
41 | MP0003950_abnormal_plasma_membrane | 1.63041389 |
42 | MP0003828_pulmonary_edema | 1.61202670 |
43 | MP0004484_altered_response_of | 1.60023084 |
44 | MP0001819_abnormal_immune_cell | 1.59933705 |
45 | MP0005319_abnormal_enzyme/_coenzyme | 1.59306855 |
46 | MP0002452_abnormal_antigen_presenting | 1.55331944 |
47 | MP0004043_abnormal_pH_regulation | 1.53919804 |
48 | MP0003690_abnormal_glial_cell | 1.53749501 |
49 | MP0005670_abnormal_white_adipose | 1.52432858 |
50 | MP0004019_abnormal_vitamin_homeostasis | 1.51495866 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48903468 |
52 | MP0005666_abnormal_adipose_tissue | 1.48406913 |
53 | MP0003656_abnormal_erythrocyte_physiolo | 1.46435514 |
54 | MP0003705_abnormal_hypodermis_morpholog | 1.43384009 |
55 | MP0002398_abnormal_bone_marrow | 1.42262082 |
56 | MP0000465_gastrointestinal_hemorrhage | 1.41882321 |
57 | MP0003868_abnormal_feces_composition | 1.41191547 |
58 | MP0009643_abnormal_urine_homeostasis | 1.37431404 |
59 | MP0006082_CNS_inflammation | 1.37394007 |
60 | MP0004185_abnormal_adipocyte_glucose | 1.32080915 |
61 | MP0001851_eye_inflammation | 1.29806535 |
62 | MP0000015_abnormal_ear_pigmentation | 1.29476543 |
63 | MP0002009_preneoplasia | 1.29171625 |
64 | MP0000920_abnormal_myelination | 1.25790584 |
65 | MP0000716_abnormal_immune_system | 1.25438341 |
66 | MP0004947_skin_inflammation | 1.24770052 |
67 | MP0003866_abnormal_defecation | 1.23077231 |
68 | MP0005058_abnormal_lysosome_morphology | 1.21414015 |
69 | MP0004036_abnormal_muscle_relaxation | 1.21131663 |
70 | MP0002405_respiratory_system_inflammati | 1.20878844 |
71 | MP0002148_abnormal_hypersensitivity_rea | 1.20766160 |
72 | MP0001764_abnormal_homeostasis | 1.18115594 |
73 | MP0009278_abnormal_bone_marrow | 1.17384641 |
74 | MP0005408_hypopigmentation | 1.17054726 |
75 | MP0002971_abnormal_brown_adipose | 1.16933726 |
76 | MP0003186_abnormal_redox_activity | 1.16397011 |
77 | MP0003011_delayed_dark_adaptation | 1.16081076 |
78 | MP0001533_abnormal_skeleton_physiology | 1.15400692 |
79 | MP0000689_abnormal_spleen_morphology | 1.15318959 |
80 | MP0010234_abnormal_vibrissa_follicle | 1.15261910 |
81 | MP0005397_hematopoietic_system_phenotyp | 1.14587138 |
82 | MP0001545_abnormal_hematopoietic_system | 1.14587138 |
83 | MP0005451_abnormal_body_composition | 1.12899849 |
84 | MP0010155_abnormal_intestine_physiology | 1.09779460 |
85 | MP0002722_abnormal_immune_system | 1.08204819 |
86 | MP0001845_abnormal_inflammatory_respons | 1.07707269 |
87 | MP0005330_cardiomyopathy | 1.07344655 |
88 | MP0000703_abnormal_thymus_morphology | 1.06639376 |
89 | MP0000604_amyloidosis | 1.06029954 |
90 | MP0005375_adipose_tissue_phenotype | 1.04382405 |
91 | MP0000749_muscle_degeneration | 1.03820558 |
92 | MP0003300_gastrointestinal_ulcer | 1.02619866 |
93 | MP0003787_abnormal_imprinting | 1.02602613 |
94 | MP0008569_lethality_at_weaning | 1.01111706 |
95 | MP0003075_altered_response_to | 1.00467876 |
96 | MP0004883_abnormal_blood_vessel | 1.00367163 |
97 | MP0008874_decreased_physiological_sensi | 0.98939198 |
98 | MP0004215_abnormal_myocardial_fiber | 0.98836615 |
99 | MP0008004_abnormal_stomach_pH | 0.98750443 |
100 | MP0006036_abnormal_mitochondrial_physio | 0.98040039 |
101 | MP0005166_decreased_susceptibility_to | 0.96766713 |
102 | MP0001661_extended_life_span | 0.96260421 |
103 | MP0009697_abnormal_copulation | 0.96247955 |
104 | MP0005310_abnormal_salivary_gland | 0.95788230 |
105 | MP0005174_abnormal_tail_pigmentation | 0.95415045 |
106 | MP0002429_abnormal_blood_cell | 0.95091597 |
107 | MP0000598_abnormal_liver_morphology | 0.95072540 |
108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94239977 |
109 | MP0004084_abnormal_cardiac_muscle | 0.92659320 |
110 | MP0005647_abnormal_sex_gland | 0.92656256 |
111 | MP0004147_increased_porphyrin_level | 0.92254869 |
112 | MP0009763_increased_sensitivity_to | 0.91572261 |
113 | MP0002998_abnormal_bone_remodeling | 0.90578788 |
114 | MP0002078_abnormal_glucose_homeostasis | 0.89897073 |
115 | MP0002269_muscular_atrophy | 0.89226757 |
116 | MP0000751_myopathy | 0.86573283 |
117 | MP0000747_muscle_weakness | 0.86347381 |
118 | MP0010678_abnormal_skin_adnexa | 0.86225290 |
119 | MP0005334_abnormal_fat_pad | 0.85051471 |
120 | MP0002106_abnormal_muscle_physiology | 0.82887674 |
121 | MP0009764_decreased_sensitivity_to | 0.82786106 |
122 | MP0008438_abnormal_cutaneous_collagen | 0.82595808 |
123 | MP0005075_abnormal_melanosome_morpholog | 0.81013369 |
124 | MP0000249_abnormal_blood_vessel | 0.80414517 |
125 | MP0002396_abnormal_hematopoietic_system | 0.79889307 |
126 | MP0004510_myositis | 0.79825881 |
127 | MP0005167_abnormal_blood-brain_barrier | 0.79484241 |
128 | MP0009333_abnormal_splenocyte_physiolog | 0.79469236 |
129 | MP0003879_abnormal_hair_cell | 0.79177764 |
130 | MP0004087_abnormal_muscle_fiber | 0.78516908 |
131 | MP0000343_altered_response_to | 0.78024738 |
132 | MP0006138_congestive_heart_failure | 0.77833089 |
133 | MP0005636_abnormal_mineral_homeostasis | 0.77592319 |
134 | MP0010368_abnormal_lymphatic_system | 0.76826658 |
135 | MP0003091_abnormal_cell_migration | 0.76688334 |
136 | MP0000759_abnormal_skeletal_muscle | 0.76418556 |
137 | MP0004381_abnormal_hair_follicle | 0.75655900 |
138 | MP0003329_amyloid_beta_deposits | 0.74557438 |
139 | MP0002877_abnormal_melanocyte_morpholog | 0.73229899 |
140 | MP0009765_abnormal_xenobiotic_induced | 0.72064923 |
141 | MP0008775_abnormal_heart_ventricle | 0.71167584 |
142 | MP0001756_abnormal_urination | 0.71137530 |
143 | MP0000003_abnormal_adipose_tissue | 0.70767579 |
144 | MP0002166_altered_tumor_susceptibility | 0.70496699 |
145 | MP0002254_reproductive_system_inflammat | 0.70413886 |
146 | MP0005535_abnormal_body_temperature | 0.68667250 |
147 | MP0003453_abnormal_keratinocyte_physiol | 0.67922056 |
148 | MP0008469_abnormal_protein_level | 0.67466689 |
149 | MP0009642_abnormal_blood_homeostasis | 0.66971233 |
150 | MP0005266_abnormal_metabolism | 0.65591971 |
151 | MP0002332_abnormal_exercise_endurance | 0.62722547 |
152 | MP0005376_homeostasis/metabolism_phenot | 0.62150005 |
153 | MP0005220_abnormal_exocrine_pancreas | 0.59544764 |
154 | MP0002796_impaired_skin_barrier | 0.59497827 |
155 | MP0003724_increased_susceptibility_to | 0.56933322 |
156 | MP0010630_abnormal_cardiac_muscle | 0.56492056 |
157 | MP0002168_other_aberrant_phenotype | 0.55303902 |
158 | MP0005620_abnormal_muscle_contractility | 0.55046140 |
159 | MP0002090_abnormal_vision | 0.53050064 |
160 | MP0009780_abnormal_chondrocyte_physiolo | 0.52234000 |
161 | MP0002136_abnormal_kidney_physiology | 0.51111390 |
162 | MP0004885_abnormal_endolymph | 0.50672138 |
163 | MP0000230_abnormal_systemic_arterial | 0.50633016 |
164 | MP0000383_abnormal_hair_follicle | 0.50030685 |
165 | MP0002972_abnormal_cardiac_muscle | 0.49915628 |
166 | MP0004145_abnormal_muscle_electrophysio | 0.48012411 |
167 | MP0003045_fibrosis | 0.47684838 |
168 | MP0002060_abnormal_skin_morphology | 0.47489351 |
169 | MP0001765_abnormal_ion_homeostasis | 0.46956729 |
170 | MP0001544_abnormal_cardiovascular_syste | 0.46845351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.42179916 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.89508572 |
3 | Deep venous thrombosis (HP:0002625) | 5.61068417 |
4 | Xanthomatosis (HP:0000991) | 5.43706828 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.99130438 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.84043169 |
7 | Complement deficiency (HP:0004431) | 4.51189492 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 4.35078461 |
9 | Hypoglycemic coma (HP:0001325) | 4.34533869 |
10 | Eczematoid dermatitis (HP:0000976) | 4.33198755 |
11 | Ketosis (HP:0001946) | 4.25255406 |
12 | Hypobetalipoproteinemia (HP:0003563) | 4.17354075 |
13 | Hyperammonemia (HP:0001987) | 4.14055650 |
14 | Epidermoid cyst (HP:0200040) | 4.06718462 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99402865 |
16 | Abnormality of glycine metabolism (HP:0010895) | 3.99402865 |
17 | Hyperglycinemia (HP:0002154) | 3.89280589 |
18 | Hyperglycinuria (HP:0003108) | 3.84692856 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.79817439 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.73308385 |
21 | Hypolipoproteinemia (HP:0010981) | 3.72495449 |
22 | Poikilocytosis (HP:0004447) | 3.66758696 |
23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64026364 |
24 | Recurrent bacterial skin infections (HP:0005406) | 3.58527518 |
25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.57131451 |
26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54250828 |
27 | Fat malabsorption (HP:0002630) | 3.50348103 |
28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47663556 |
29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.47511981 |
30 | Ketoacidosis (HP:0001993) | 3.44434908 |
31 | Abnormality of methionine metabolism (HP:0010901) | 3.44017948 |
32 | Myositis (HP:0100614) | 3.40787036 |
33 | Optic neuritis (HP:0100653) | 3.38258842 |
34 | Retrobulbar optic neuritis (HP:0100654) | 3.38258842 |
35 | Orchitis (HP:0100796) | 3.36713792 |
36 | Recurrent abscess formation (HP:0002722) | 3.36231780 |
37 | Muscle fiber inclusion bodies (HP:0100299) | 3.35330933 |
38 | T lymphocytopenia (HP:0005403) | 3.35196895 |
39 | Joint hemorrhage (HP:0005261) | 3.29224268 |
40 | Spontaneous hematomas (HP:0007420) | 3.23359670 |
41 | Nemaline bodies (HP:0003798) | 3.19632615 |
42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19554555 |
43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.17975060 |
44 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.16979806 |
45 | Abnormality of T cell number (HP:0011839) | 3.16729329 |
46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.16603667 |
47 | Gastrointestinal infarctions (HP:0005244) | 3.15245069 |
48 | Hypercholesterolemia (HP:0003124) | 3.11597674 |
49 | Abnormality of complement system (HP:0005339) | 3.11430584 |
50 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.99520493 |
51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93906907 |
52 | Prolonged bleeding time (HP:0003010) | 2.92323032 |
53 | Myocardial infarction (HP:0001658) | 2.87421565 |
54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85967130 |
55 | Papilledema (HP:0001085) | 2.82330953 |
56 | Skin nodule (HP:0200036) | 2.82108787 |
57 | Stomatitis (HP:0010280) | 2.81235293 |
58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.77014554 |
59 | Keratoconjunctivitis sicca (HP:0001097) | 2.76255601 |
60 | Dicarboxylic aciduria (HP:0003215) | 2.76225097 |
61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76225097 |
62 | Hyporeflexia of lower limbs (HP:0002600) | 2.74138330 |
63 | Myoglobinuria (HP:0002913) | 2.71809871 |
64 | Hypoglycemic seizures (HP:0002173) | 2.70570585 |
65 | Steatorrhea (HP:0002570) | 2.70474684 |
66 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.67883888 |
67 | Hyperbilirubinemia (HP:0002904) | 2.66509526 |
68 | Vasculitis (HP:0002633) | 2.65072492 |
69 | Abnormal gallbladder morphology (HP:0012437) | 2.61533154 |
70 | Recurrent fungal infections (HP:0002841) | 2.60326192 |
71 | Abnormality of macrophages (HP:0004311) | 2.59766038 |
72 | Calf muscle hypertrophy (HP:0008981) | 2.59524300 |
73 | Abnormality of purine metabolism (HP:0004352) | 2.59511268 |
74 | Subaortic stenosis (HP:0001682) | 2.58368656 |
75 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.58368656 |
76 | Vascular calcification (HP:0004934) | 2.57813121 |
77 | EMG: myopathic abnormalities (HP:0003458) | 2.57445735 |
78 | Metabolic acidosis (HP:0001942) | 2.55985417 |
79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55353283 |
80 | Chest pain (HP:0100749) | 2.55260941 |
81 | Microcytic anemia (HP:0001935) | 2.54292313 |
82 | Delayed CNS myelination (HP:0002188) | 2.53847365 |
83 | Keratoconjunctivitis (HP:0001096) | 2.48350379 |
84 | Abnormality of serum amino acid levels (HP:0003112) | 2.45025364 |
85 | Epistaxis (HP:0000421) | 2.44441403 |
86 | Cholelithiasis (HP:0001081) | 2.44047254 |
87 | Hemiplegia (HP:0002301) | 2.43928415 |
88 | Gout (HP:0001997) | 2.43502694 |
89 | Polycythemia (HP:0001901) | 2.42974787 |
90 | Hepatocellular carcinoma (HP:0001402) | 2.42038599 |
91 | Gingivitis (HP:0000230) | 2.41417302 |
92 | Recurrent skin infections (HP:0001581) | 2.40819878 |
93 | Meningitis (HP:0001287) | 2.40337927 |
94 | Slow saccadic eye movements (HP:0000514) | 2.40264960 |
95 | Autoimmune hemolytic anemia (HP:0001890) | 2.38591593 |
96 | Encephalitis (HP:0002383) | 2.38588638 |
97 | Hypochromic microcytic anemia (HP:0004840) | 2.36813927 |
98 | Hypochromic anemia (HP:0001931) | 2.36556382 |
99 | Cardiovascular calcification (HP:0011915) | 2.36245920 |
100 | Exercise-induced myalgia (HP:0003738) | 2.33598411 |
101 | Bundle branch block (HP:0011710) | 2.33398668 |
102 | Postural instability (HP:0002172) | 2.32687161 |
103 | Systemic lupus erythematosus (HP:0002725) | 2.32106294 |
104 | Frequent falls (HP:0002359) | 2.31856563 |
105 | Sudden death (HP:0001699) | 2.31790558 |
106 | Hemorrhage of the eye (HP:0011885) | 2.30836836 |
107 | Exercise-induced muscle cramps (HP:0003710) | 2.29924500 |
108 | Arterial thrombosis (HP:0004420) | 2.29654221 |
109 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.29643990 |
110 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29442965 |
111 | Generalized aminoaciduria (HP:0002909) | 2.28001285 |
112 | Type 1 muscle fiber predominance (HP:0003803) | 2.26804764 |
113 | Increased IgE level (HP:0003212) | 2.24679584 |
114 | Ventricular fibrillation (HP:0001663) | 2.23996441 |
115 | Diplopia (HP:0000651) | 2.22424971 |
116 | Abnormality of binocular vision (HP:0011514) | 2.22424971 |
117 | Recurrent cutaneous fungal infections (HP:0011370) | 2.21623456 |
118 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.21623456 |
119 | Pulmonary embolism (HP:0002204) | 2.21170540 |
120 | Pulmonary infiltrates (HP:0002113) | 2.19303171 |
121 | Esophageal varix (HP:0002040) | 2.18253645 |
122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.16947065 |
123 | Spastic diplegia (HP:0001264) | 2.15959596 |
124 | Hyperglycemia (HP:0003074) | 2.15825789 |
125 | Acanthocytosis (HP:0001927) | 2.13212376 |
126 | Mediastinal lymphadenopathy (HP:0100721) | 2.12028640 |
127 | Leukocytosis (HP:0001974) | 2.11774055 |
128 | Neurofibrillary tangles (HP:0002185) | 2.11581318 |
129 | Abnormality of T cells (HP:0002843) | 2.08751965 |
130 | Asymmetric septal hypertrophy (HP:0001670) | 2.07839844 |
131 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07340906 |
132 | Vertigo (HP:0002321) | 2.07244792 |
133 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06232983 |
134 | Obstructive lung disease (HP:0006536) | 2.06232983 |
135 | Pancreatitis (HP:0001733) | 2.04694335 |
136 | EMG: neuropathic changes (HP:0003445) | 2.04203812 |
137 | Recurrent viral infections (HP:0004429) | 2.02808714 |
138 | Lethargy (HP:0001254) | 2.02717279 |
139 | Hemoptysis (HP:0002105) | 2.02332483 |
140 | Amyloidosis (HP:0011034) | 2.00703906 |
141 | Inflammation of the large intestine (HP:0002037) | 2.00391324 |
142 | Right ventricular cardiomyopathy (HP:0011663) | 1.96271776 |
143 | Pustule (HP:0200039) | 1.96094703 |
144 | Osteomyelitis (HP:0002754) | 1.95161622 |
145 | Gingival bleeding (HP:0000225) | 1.94934888 |
146 | Urticaria (HP:0001025) | 1.94895226 |
147 | Muscle fiber splitting (HP:0003555) | 1.94670889 |
148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93932183 |
149 | Abnormality of the fingertips (HP:0001211) | 1.93294841 |
150 | Increased connective tissue (HP:0009025) | 1.91911840 |
151 | Foot dorsiflexor weakness (HP:0009027) | 1.91543416 |
152 | Spontaneous abortion (HP:0005268) | 1.91300596 |
153 | Irritability (HP:0000737) | 1.91046687 |
154 | Rhabdomyolysis (HP:0003201) | 1.90528873 |
155 | Colitis (HP:0002583) | 1.89299548 |
156 | Cellulitis (HP:0100658) | 1.88803892 |
157 | Abnormal platelet volume (HP:0011876) | 1.88700869 |
158 | Abnormality of vitamin metabolism (HP:0100508) | 1.88214217 |
159 | Abnormality of the foot musculature (HP:0001436) | 1.88002400 |
160 | Visual hallucinations (HP:0002367) | 1.87523170 |
161 | Cerebral edema (HP:0002181) | 1.86941568 |
162 | Abnormality of the gallbladder (HP:0005264) | 1.86039855 |
163 | Abnormality of the endocardium (HP:0004306) | 1.85442088 |
164 | Rickets (HP:0002748) | 1.83818056 |
165 | Toxemia of pregnancy (HP:0100603) | 1.83708791 |
166 | Gangrene (HP:0100758) | 1.83100587 |
167 | Back pain (HP:0003418) | 1.83058201 |
168 | Vomiting (HP:0002013) | 1.82411392 |
169 | Eosinophilia (HP:0001880) | 1.82190509 |
170 | Recurrent bronchitis (HP:0002837) | 1.81649707 |
171 | Axonal loss (HP:0003447) | 1.81511821 |
172 | Increased purine levels (HP:0004368) | 1.79763173 |
173 | Hyperuricemia (HP:0002149) | 1.79763173 |
174 | Mitral stenosis (HP:0001718) | 1.79687448 |
175 | Symptomatic seizures (HP:0011145) | 1.79675420 |
176 | Gastrointestinal inflammation (HP:0004386) | 1.79529608 |
177 | Sensorimotor neuropathy (HP:0007141) | 1.79511286 |
178 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79468266 |
179 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79468266 |
180 | Glomerulonephritis (HP:0000099) | 1.79451950 |
181 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78998737 |
182 | Hydroxyprolinuria (HP:0003080) | 1.78619308 |
183 | Abnormality of proline metabolism (HP:0010907) | 1.78619308 |
184 | Abnormality of the calf musculature (HP:0001430) | 1.78334872 |
185 | Difficulty running (HP:0009046) | 1.77316829 |
186 | Late onset (HP:0003584) | 1.76886798 |
187 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.76648302 |
188 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75341480 |
189 | Pigmentary retinal degeneration (HP:0001146) | 1.75157378 |
190 | Cerebral hemorrhage (HP:0001342) | 1.74954506 |
191 | Renal cortical cysts (HP:0000803) | 1.72715688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.32850919 |
2 | RIPK4 | 3.45009369 |
3 | EPHB1 | 3.24188148 |
4 | STK39 | 3.06842196 |
5 | PRPF4B | 2.75194292 |
6 | FGFR2 | 2.57565466 |
7 | FGFR4 | 2.51001947 |
8 | SIK1 | 2.49171164 |
9 | INSRR | 2.36791849 |
10 | BLK | 2.21255914 |
11 | MAP4K1 | 2.20960159 |
12 | TTN | 2.11718205 |
13 | MET | 2.03499501 |
14 | GRK6 | 1.99368588 |
15 | TRIB3 | 1.96796249 |
16 | FRK | 1.86359499 |
17 | RIPK1 | 1.82490193 |
18 | FES | 1.80483875 |
19 | TAOK3 | 1.77181632 |
20 | WNK4 | 1.76690182 |
21 | SGK2 | 1.76029418 |
22 | PKN2 | 1.75628709 |
23 | TXK | 1.71896623 |
24 | ERN1 | 1.71536625 |
25 | CAMK1D | 1.65917528 |
26 | SYK | 1.63555456 |
27 | LATS1 | 1.63188872 |
28 | MAP3K13 | 1.62771317 |
29 | ZAP70 | 1.60575248 |
30 | OBSCN | 1.55245857 |
31 | OXSR1 | 1.49369468 |
32 | PHKG2 | 1.46772789 |
33 | PHKG1 | 1.46772789 |
34 | KSR2 | 1.45764375 |
35 | PKN1 | 1.42093876 |
36 | WNK1 | 1.41379841 |
37 | PTK6 | 1.40914224 |
38 | IRAK4 | 1.40701223 |
39 | BTK | 1.35599896 |
40 | PRKAA2 | 1.33730240 |
41 | FGR | 1.32755455 |
42 | PDK3 | 1.30932797 |
43 | PDK4 | 1.30932797 |
44 | BMPR2 | 1.28511564 |
45 | PINK1 | 1.26941937 |
46 | PDK2 | 1.25861922 |
47 | MAP3K1 | 1.25267873 |
48 | PTK2B | 1.22609423 |
49 | TNK2 | 1.22473355 |
50 | JAK3 | 1.21812519 |
51 | MST1R | 1.19582997 |
52 | FLT3 | 1.17762151 |
53 | TEC | 1.16215237 |
54 | TYK2 | 1.15752906 |
55 | CAMK1G | 1.15387390 |
56 | PIK3CG | 1.15149356 |
57 | HCK | 1.14143254 |
58 | MAP3K7 | 1.13269113 |
59 | PIK3CA | 1.11369861 |
60 | TAOK1 | 1.10044416 |
61 | TGFBR2 | 1.09696809 |
62 | MARK3 | 1.09402315 |
63 | JAK1 | 1.08866769 |
64 | NTRK3 | 1.08796682 |
65 | ERBB4 | 1.06387052 |
66 | TRPM7 | 1.05858131 |
67 | FGFR3 | 1.04303292 |
68 | GRK5 | 1.01566919 |
69 | PBK | 1.00672659 |
70 | JAK2 | 0.99543008 |
71 | GSK3A | 0.94435283 |
72 | PRKD1 | 0.91690904 |
73 | PRKAA1 | 0.90866352 |
74 | TIE1 | 0.89989180 |
75 | MARK2 | 0.89473072 |
76 | LYN | 0.87677054 |
77 | YES1 | 0.86979524 |
78 | NEK9 | 0.85603832 |
79 | PDPK1 | 0.84641216 |
80 | SGK1 | 0.83975500 |
81 | SGK223 | 0.83830132 |
82 | SGK494 | 0.83830132 |
83 | KSR1 | 0.82648935 |
84 | MAP2K3 | 0.82148638 |
85 | IRAK1 | 0.78873854 |
86 | LCK | 0.78798327 |
87 | MAPK15 | 0.78200120 |
88 | CSK | 0.77820089 |
89 | MAPK11 | 0.76472879 |
90 | STK38 | 0.75209959 |
91 | LMTK2 | 0.74382218 |
92 | PIM1 | 0.72999822 |
93 | EPHA3 | 0.72325812 |
94 | MAP3K2 | 0.72243126 |
95 | NLK | 0.71733649 |
96 | PDK1 | 0.71516881 |
97 | STK11 | 0.69720917 |
98 | PAK3 | 0.68363829 |
99 | ICK | 0.67667501 |
100 | CAMK2G | 0.66946092 |
101 | MAP3K10 | 0.66480189 |
102 | MST4 | 0.65958124 |
103 | CDK6 | 0.65602071 |
104 | PRKCQ | 0.64187284 |
105 | CAMK4 | 0.62327747 |
106 | RAF1 | 0.62270336 |
107 | DAPK2 | 0.61209655 |
108 | SGK3 | 0.60955098 |
109 | UHMK1 | 0.59900465 |
110 | MAPK12 | 0.59845076 |
111 | NTRK2 | 0.59739379 |
112 | MAP2K4 | 0.59354563 |
113 | NEK6 | 0.59099935 |
114 | CAMKK1 | 0.58328973 |
115 | PRKCH | 0.57898605 |
116 | DYRK1B | 0.57744278 |
117 | STK3 | 0.57694384 |
118 | RET | 0.57324634 |
119 | MAP3K6 | 0.56953225 |
120 | CDC42BPA | 0.56285183 |
121 | IRAK2 | 0.55949031 |
122 | CAMKK2 | 0.55659236 |
123 | STK10 | 0.55448769 |
124 | MAP3K14 | 0.54994831 |
125 | MAP2K2 | 0.53362019 |
126 | PDGFRA | 0.52501346 |
127 | FYN | 0.52417815 |
128 | MAP3K5 | 0.52309756 |
129 | CSF1R | 0.52198432 |
130 | MAP3K3 | 0.52132351 |
131 | CAMK2D | 0.52031503 |
132 | BMX | 0.51927920 |
133 | ACVR1B | 0.51837230 |
134 | HIPK2 | 0.51777539 |
135 | ITK | 0.50713507 |
136 | STK4 | 0.49298857 |
137 | IKBKE | 0.48636330 |
138 | PDGFRB | 0.48613724 |
139 | PRKACG | 0.48370034 |
140 | MAP3K11 | 0.48015689 |
141 | DYRK1A | 0.47954140 |
142 | TBK1 | 0.47587297 |
143 | CSNK1A1L | 0.47210197 |
144 | MAPKAPK5 | 0.47169706 |
145 | DMPK | 0.46583225 |
146 | MTOR | 0.43747468 |
147 | LRRK2 | 0.43650102 |
148 | MYLK | 0.43242033 |
149 | PTK2 | 0.42853294 |
150 | CSNK1G1 | 0.42778243 |
151 | IRAK3 | 0.39270566 |
152 | MAPK7 | 0.39213691 |
153 | GRK1 | 0.38355712 |
154 | AKT3 | 0.37907311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.18022513 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.50777622 |
3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.86246430 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77607139 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73977557 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69294468 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.66027117 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.62597841 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54113001 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38651759 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37564712 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21889271 |
13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20646381 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18116911 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15244232 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02134962 |
17 | Peroxisome_Homo sapiens_hsa04146 | 1.99458765 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96997602 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95205285 |
20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94435266 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85281454 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77822378 |
23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77800058 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77728144 |
25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77529725 |
26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73364088 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70551574 |
28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69074601 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68832581 |
30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65379157 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65181231 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61182410 |
33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58938776 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58769633 |
35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50212910 |
36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46922931 |
37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.46197985 |
38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46112949 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45204770 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43637301 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43255912 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43176718 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.43150031 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41459620 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.39572136 |
46 | Platelet activation_Homo sapiens_hsa04611 | 1.37974059 |
47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.37755191 |
48 | Malaria_Homo sapiens_hsa05144 | 1.36433610 |
49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32970046 |
50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32751852 |
51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32738799 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31228441 |
53 | Tuberculosis_Homo sapiens_hsa05152 | 1.30395651 |
54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25593332 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23331634 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19104254 |
57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18582059 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18566007 |
59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18069439 |
60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17419918 |
61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17323898 |
62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.16967389 |
63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16244161 |
64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16162583 |
65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15107667 |
66 | Measles_Homo sapiens_hsa05162 | 1.11660816 |
67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10443923 |
68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10113511 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09359736 |
70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09168827 |
71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07987488 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06604676 |
73 | Renin secretion_Homo sapiens_hsa04924 | 1.05104992 |
74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.04777460 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02839902 |
76 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02288308 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02096260 |
78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01857725 |
79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01792631 |
80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01457285 |
81 | Lysine degradation_Homo sapiens_hsa00310 | 1.01352863 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00226979 |
83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99857896 |
84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99758170 |
85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99297910 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99282779 |
87 | Allograft rejection_Homo sapiens_hsa05330 | 0.98206913 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98027072 |
89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97963194 |
90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97890724 |
91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96182382 |
92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95765158 |
93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95743495 |
94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95542933 |
95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95200889 |
96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94561627 |
97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93248794 |
98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91548343 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90397205 |
100 | Glioma_Homo sapiens_hsa05214 | 0.89683479 |
101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89234617 |
102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87820357 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87713350 |
104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87169045 |
105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86421351 |
106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84997229 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84475353 |
108 | Influenza A_Homo sapiens_hsa05164 | 0.82300684 |
109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80995070 |
110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78164428 |
111 | Long-term depression_Homo sapiens_hsa04730 | 0.78070964 |
112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77498488 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77301733 |
114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76901593 |
115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75739831 |
116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75648751 |
117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74700146 |
118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74099847 |
119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73771351 |
120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73236416 |
121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72761865 |
122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71978819 |
123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70590201 |
124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70222244 |
125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69510512 |
126 | Hepatitis B_Homo sapiens_hsa05161 | 0.69065049 |
127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69056702 |
128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68867832 |
129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67623785 |
130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67552841 |
131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67417282 |
132 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66516915 |
133 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64011251 |
134 | Morphine addiction_Homo sapiens_hsa05032 | 0.63873004 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63255425 |
136 | Salivary secretion_Homo sapiens_hsa04970 | 0.63237932 |
137 | Insulin resistance_Homo sapiens_hsa04931 | 0.61764523 |
138 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61675055 |
139 | Legionellosis_Homo sapiens_hsa05134 | 0.59518702 |
140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57375512 |
141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57373370 |
142 | Insulin secretion_Homo sapiens_hsa04911 | 0.57150132 |
143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55099659 |
144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54045550 |
145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45956197 |
146 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40625149 |
147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39310250 |
148 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39064070 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37731197 |
150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36142666 |
151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32587888 |
152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31474388 |
153 | Prion diseases_Homo sapiens_hsa05020 | 0.25324557 |
154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24439709 |
155 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23607544 |
156 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22500646 |
157 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15382382 |
158 | Lysosome_Homo sapiens_hsa04142 | 0.08763085 |
159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.08040484 |
160 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07771740 |
161 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.05099794 |
162 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.05063960 |
163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04611337 |
164 | Amoebiasis_Homo sapiens_hsa05146 | 0.04387603 |
165 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04326076 |
166 | Mineral absorption_Homo sapiens_hsa04978 | 0.02909127 |
167 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02806984 |
168 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.02150407 |
169 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00654374 |
170 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.00534470 |
171 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0527781 |
172 | Hepatitis C_Homo sapiens_hsa05160 | -0.0494866 |
173 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0253519 |
174 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0247930 |
175 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0186813 |
176 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0182003 |
177 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0125750 |
178 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0116903 |